Utility Menu French

National Association of Pharmacy Regulatory Authorities

Provinces French

Main navigation French


Recherchez dans la base de données des Annexes nationales de médicaments

Commencez votre recherche en utilisant le nom générique du produit :

Recherche par annexe
Réinitialiser

ATTENTION : Tous les résultats de la recherche seront tirés du « National Drug Schedules » du site Web en anglais.

Nom du médicament (en anglais) Commentaire Annexe Date
Dipivefrin or its saltsPDL I DEC / 13
Diprophylline or its saltsPDL I DEC / 13
DipyridamolePDL I DEC / 13
DirithromycinPDL

For human use

I DEC / 13
DirlotapidePDL I DEC / 13
Disopyramide or its saltsPDL I DEC / 13
DisulfiramPDL I DEC / 13
Dithranol Anthralin II SEP / 98
Dobutamine or its saltsPDL I DEC / 13
Docetaxel or its derivativesPDL

including but not limited to cabazitaxel

I DEC / 13
Docusate and its salts U
Dolasetron or its saltsPDL I DEC / 13
Dolutegravir or its saltsPDL I DEC / 13
DomperidonePDL I DEC / 13
Donepezil or its saltsPDL I DEC / 13
Dopamine or its saltsPDL

when sold for administration by injection

I DEC / 13
DoravirinePDL I NOV / 18
Dornase alfaPDL I DEC / 13
Dorzolamide or its saltsPDL I DEC / 13
Doxacurium chloridePDL I DEC / 13
DoxapramPDL I DEC / 13
Doxazosin or its saltsPDL I DEC / 13
Doxepin or its saltsPDL I DEC / 13
Doxercalciferol or its derivativesPDL I DEC / 13
Doxorubicin or its saltsPDL I DEC / 13
Doxycycline or its salts or derivativesPDL

including but not limited to doxycycline hyclate, doxycycline monohydrate

I DEC / 13
Doxylamine or its salts

except those sold for nausea and vomiting of pregnancy

III SEP / 98
Doxylamine or its saltsPDL

when sold or recommended for use in the nausea or vomiting of pregnancy

I DEC / 13
Droperidol or its saltsPDL I DEC / 13
DrotrecoginPDL I DEC / 13
DulaglutidePDL I JAN / 16
Duloxetine or its saltsPDL I DEC / 13
DupilumabPDL I MAR / 18
DurvalumabPDL I DEC / 17
DutasteridePDL I DEC / 13
Dyclonine except for topical use on mucous membranes II SEP / 98
Dyclonine and its salts for topical use on mucous membranes, except lozenges III SEP / 98

137 résultats


Footnotes

  • C - Drug is listed in the Schedule to Part G of the Food and Drug Regulations under the Controlled Drugs and Substances Act
    N - Drug is listed in the Narcotic Control Regulations under the Controlled Drugs and Substances Act
    NR - Drug has not been reviewed by the NDSAC
    PDL - Drug is listed in the Health Canada Prescription Drug List
    TS - Drug is listed in the Benzodiazepines and Other Targeted Substances Regulations under the Controlled Drugs and Substances Act
    CR - Drug has been recommended for addition to the Controlled Drugs and Substances Act